Nuclomed Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.00 M
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 357.82%
- Ebitda -2363.64%
- Net Worth 493.27%
- Total Assets 760.72%
About Nuclomed Pharmaceuticals
Nuclomed Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 October 2019 (Five years and three months 23 days old ). Its registered office is in Moradabad, Uttar Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Nazrul Islam, Hareswar Borah, Shoiab Khan, and Two other members serve as directors at the Company.
Company Details
- Location
Moradabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24299UP2019PTC122039
- Company No.
122039
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Nuclomed Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nazrul Islam  | Director | 07-Oct-2019 | Current |
| Hareswar Borah | Director | 07-Oct-2019 | Current |
| Shoiab Khan | Director | 07-Oct-2019 | Current |
| Robertson Timung | Director | 07-Oct-2019 | Current |
| Syeda Begum | Director | 05-Nov-2019 | Current |
Financial Performance of Nuclomed Pharmaceuticals.
Nuclomed Pharmaceuticals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 357.82% increase in profit. The company's net worth Soared by an impressive increase of 493.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nuclomed Pharmaceuticals?
Unlock access to Nuclomed Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sirin Sisters Health Care Private LimitedNazrul Islam is a mutual person
- Raahat Lifecare & Services Private Limited
Nazrul Islam is a mutual person
- Ka Organics Private Limited
Shoiab Khan is a mutual person
- Instahealth Solutions Private Limited
Syeda Begum is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nuclomed Pharmaceuticals?
Unlock and access historical data on people associated with Nuclomed Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nuclomed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuclomed Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
